Trial intelligence / Profile preview

Metformin and ucOC in Lean PCOS Women

NCT02244567Phase 1Unknown

Sponsor
Beni Suef University
Start
Sep 2014
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Beni Suef University. Primary endpoint: under-carboxylated osteocalcin at 3 months. Status: unknown.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02244567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02244567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call